Matches in Nanopublications for { ?s ?p "[Therefore, inhibitors of transglutaminase 2 should be considered as possible therapeutics for OPMD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP558119.RAhx_b6VFxZq5q6FIUr_8SS3jlQSYPtdHUBI1-lD1nkz8130_assertion description "[Therefore, inhibitors of transglutaminase 2 should be considered as possible therapeutics for OPMD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558119.RAhx_b6VFxZq5q6FIUr_8SS3jlQSYPtdHUBI1-lD1nkz8130_provenance.
- assertion description "[Therefore, inhibitors of transglutaminase 2 should be considered as possible therapeutics for OPMD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP735038.RAnDfCo4SVkd3GMVl6tP-oQCfCeOLS3isdyyENTmfEhpA130_assertion description "[Therefore, inhibitors of transglutaminase 2 should be considered as possible therapeutics for OPMD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735038.RAnDfCo4SVkd3GMVl6tP-oQCfCeOLS3isdyyENTmfEhpA130_provenance.
- NP816282.RArIeXwyVhSqs6KiaEKOk5E045jgSxjlShb6ujz65mZD4130_assertion description "[Therefore, inhibitors of transglutaminase 2 should be considered as possible therapeutics for OPMD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816282.RArIeXwyVhSqs6KiaEKOk5E045jgSxjlShb6ujz65mZD4130_provenance.